Promising phase 2B trial results of Lanifibranor in NASH
Hosts
Prof. Manuel Castro Cabezas
Scientific Officer
Manuel is a senior consultant for endocrinology, internal medicine, and vascular diseases at the Franciscus Gasthuis Rotterdam and associate professor of medicine at Erasmus Medical Center, Rotterdam, the Netherlands.
Hosts
Prof. dr. Christophe Moreno, M.D.
Scientific Officer
Christophe is a professor in gastroenterology and hepatology and clinical director of the liver unit at CUB Hôpital Erasme, Brussels, Belgium. He is an important consultant to the NASH Clinical team.
During this webinar Prof. Sven Francque discussed the phase 2 trial results of the Pan-PPAR Agonist Lanifibranor in nonalcoholic steatohepatitis (NASH) patients. Currently there is an unmet need of management of NASH. Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that modulates key metabolic, inflammatory, and fibrogenic pathways in the pathogenesis of NASH and shows promising results as treatment.
Speaker: Prof. Sven Francque
Host: Dr. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
LIVE WEBINAR | NOVEMBER 26 - 2024 | 17.00 CET Time to event trial designs in ALS: How useful are they? During the webinar hosted by Lieza Exalto, Ruben van Eijk, Lotte Smets and Jordi van Unnik will touch upon:An introduction to event-driv...
Webinar – Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical Trial
On December 12th, we organised the webinar:Revolutionizing Kidney Failure Treatment: Clinical Impact and Lessons Learned from the CONVINCE Clinical TrialDuring this webinar, our speaker and hosts explored the following topics:Study d...
Webinar: Lifestyle Interventions in NAFLD/NASH
On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...